Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03431181
NA

Optimal VAsopressor TitraTION in Patients 65 Years and Older

Sponsor: Université de Sherbrooke

View on ClinicalTrials.gov

Summary

We have designed OVATION-65 to evaluate the effects of permissive low blood pressure compared to usual care on markers of organ injury and survival in older patients.

Official title: Optimal VAsopressor TitraTION in Patients 65 Years and Older (OVATION-65)

Key Details

Gender

All

Age Range

65 Years - Any

Study Type

INTERVENTIONAL

Enrollment

159

Start Date

2018-02-16

Completion Date

2024-12-31

Last Updated

2024-05-16

Healthy Volunteers

No

Interventions

BEHAVIORAL

MAP target 60-65 mmHg

Treating teams will adjust vasopressors to a target MAP range of 60 to 65 mmHg, avoiding vasopressor-induced MAP above this range.

BEHAVIORAL

Usual care

Patients in the control arm will receive usual care (as per local practices).

Locations (1)

CIUSSS de l'Estrie-CHUS

Sherbrooke, Quebec, Canada